Logos Global Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-650,000
| Closed | -$21.8M | – | 59 |
|
|
2025
Q1 | $21.8M | Buy |
+650,000
| New | +$21.8M | 3.88% | 7 |
|
|
2024
Q3 | – | Sell |
-375,000
| Closed | -$14.6M | – | 66 |
|
|
2024
Q2 | $14.6M | Buy |
+375,000
| New | +$14.6M | 1.18% | 21 |
|
|
2024
Q1 | – | Sell |
-150,000
| Closed | -$6.91M | – | 66 |
|
|
2023
Q4 | $6.91M | Sell |
150,000
-300,000
| -67% | -$13.8M | 0.64% | 30 |
|
|
2023
Q3 | $15.4M | Buy |
450,000
+175,000
| +64% | +$5.98M | 2.05% | 16 |
|
|
2023
Q2 | $10.6M | Sell |
275,000
-625,000
| -69% | -$24.1M | 1.44% | 21 |
|
|
2023
Q1 | $32.2M | Hold |
900,000
| – | – | 4.61% | 6 |
|
|
2022
Q4 | $35.5M | Buy |
900,000
+400,000
| +80% | +$15.8M | 4.16% | 7 |
|
|
2022
Q3 | $18.1M | Buy |
+500,000
| New | +$18.1M | 2.22% | 17 |
|